Evidence map›Paper›PMID 37446291›Full record

ArticleInternational journal of molecular sciences2023

LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model.

Wei Zheng, Xiao Han, Bing Han, Gang Li, Jing Gan, Tian Wang, Bo Xu, Jie He, Wenxiao Du, Xiaolin Cao and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neurodegenerative Disease: From Molecular Basis to Therapy.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Wei ZhengCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.ORCID 0000-0002-6251-5670
Xiao HanCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
Bing HanCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
Gang LiCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.ORCID 0000-0002-5743-0963
Jing GanCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
Tian WangSchool of Pharmacy, Yantai University, Yantai 264005, China.
Bo XuCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
Jie HeCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
Wenxiao DuCollege of Life Sciences, Yantai University, Yantai 264005, China.
Xiaolin CaoCollege of Life Sciences, Yantai University, Yantai 264005, China.
Zhenhua WangCenter for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.ORCID 0000-0002-7347-8561
Yantai University · CN

Funding

Qinghai Province Applied Basic Research Project 2020-ZJ-905
6 · The paper itself

Abstract

Leukocyte common antigen-related protein tyrosine phosphatase (LAR) is a member of the protein tyrosine phosphatase family that serves as a key regulator of cellular survival. It is also involved in neurodevelopment and brain disorders. This study was designed to investigate the role of LAR in a cell-based model of Parkinson's disease (PD) in which U251 and SH-SY5Y cells were used as models of astrocytes and dopaminergic neurons, respectively. Cell viability, cell death, cell morphology, protein phosphorylation and expression, ATP levels, reactive oxygen species (ROS) generation, and mitochondrial membrane potential were analyzed in the wild-type (WT) and heterozygous LAR-knockout astrocytoma U251 cells to assess the cell state, signal transduction, and mitochondrial function. LAR downregulation showed a protective effect in rotenone-exposed U251 cells by increasing cell viability, reducing cell mortality, and restoring appropriate cellular morphology. LAR downregulation enhanced IGF-1R phosphorylation and downstream signal transduction as evidenced by increases in the Akt and GSK-3β phosphorylation, as well as the upregulation of NRF2 and HO-1. The downregulation of LAR also augmented DJ-1 levels in these cells. The enhanced Akt and GSK-3β phosphorylation contributed to a reduced Bax/Bcl2 ratio and suppressed apoptosis after rotenone exposure. Heterozygous LAR-knockout U251 cells exhibited higher mitochondrial function evidenced by increased mitochondrial membrane potential, ATP contents, and reduced ROS production compared to the WT cells following rotenone exposure. Further studies showed that the astrocytic protection mediated by the heterozygous knockout of LAR was associated with the activation of Akt. A specific Akt inhibitor, MK2206, reduced the cell viability, Akt and GSK3β phosphorylation, and HO-1 and NRF2 expression in U251 cells exposed to rotenone. Astrocytes provide structural and metabolic support to maintain neuronal health. Astrocytic glial cell-derived neurotrophic factor (GDNF) production is vital for dopaminergic neuron survival. Heterozygous LAR-knockout U251 cells produced higher amounts of GDNF than the WT cells. The SH-SY5Y cells cocultured with heterozygous LAR-knockout U251 cells exhibited greater viability than that of cells cocultured with WT U251 cells in response to rotenone. Together, these findings demonstrate that the heterozygous knockout of LAR in astrocytes can play a key role in protecting both astrocytic cells and cocultured neurons in a rotenone-induced cell-based model of PD. This neuroprotective effect is attributable to the augmentation of IGF1R-Akt-GDNF signaling and the maintenance of astrocytic mitochondrial function.

Indexed as

NeuroblastomaNeuroprotective AgentsParkinson DiseaseAdenosine TriphosphateApoptosisAstrocytesDopaminergic NeuronsDown-RegulationGlial Cell Line-Derived Neurotrophic FactorGlycogen Synthase Kinase 3 betaHumansNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktReactive Oxygen SpeciesRotenoneAdenosine TriphosphateGlial Cell Line-Derived Neurotrophic FactorGlycogen Synthase Kinase 3 betaNeuroprotective AgentsNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktReactive Oxygen SpeciesRotenoneastrocyteLARmitochondrial functionneuronParkinson’s diseaserotenone

Identifiers

PMID37446291
PMCPMC10342603
OpenAlexW4383368445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.